Over 30 global pharma clients trust ROIS to deliver compliant, high-capacity manufacturing with precision and speed. As one of the top three CDMOs for injectables worldwide, we offer endto-end, cross-format support with approvals from major regulators. A dedicated NPI team at each of our sites ensures seamless tech transfer and rapid scale-up. Recent capacity investments align fully with the revised EU GMP Annex 1 standards, as confirmed by multiple post-enforcement inspections. At ROIS, we’re ready to meet today’s demand and support tomorrow’s developments.